Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea
It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...
346 Views
ASTA IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the company's growth potential and appropriate valuation level.Who is ASTA again? The company is a biomass...
535 Views
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4k Views
ASTA IPO Part 1 - Schedule, Financials & Valuation
ASTA (Applied Surface Technology) (established in 2006) submitted the IPO report. ASTA is a technology-based company that develops and manufactures...
263 Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.4k Views